Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (SHE:300452)
China
· Delayed Price · Currency is CNY 11.93
+0.09 (0.76%)
Apr 30, 2025, 3:04 PM CST
SHE:300452 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 117.89 | 120.52 | 161.54 | 130.71 | 89.25 | 93.94 | Upgrade
|
| Depreciation & Amortization | 50.75 | 50.75 | 38.73 | 36.06 | 34.68 | 31.76 | Upgrade
|
| Other Amortization | 0.42 | 0.42 | 0.34 | 0.13 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.11 | -0.11 | 0.01 | 0.27 | 0.12 | 0.55 | Upgrade
|
| Asset Writedown & Restructuring Costs | 42.27 | 42.27 | 1.02 | 0.01 | 8.97 | 1.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | -19.38 | -19.38 | -19.05 | -5.11 | -7.83 | -4.2 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.05 | -0.04 | -0.01 | -0.17 | Upgrade
|
| Other Operating Activities | 17.31 | 10.85 | 7.04 | -1.13 | -2.23 | 1.17 | Upgrade
|
| Change in Accounts Receivable | -96.59 | -96.59 | -42.25 | -98.58 | -28.04 | -48.23 | Upgrade
|
| Change in Inventory | 5.34 | 5.34 | -2.91 | -13.43 | -28.91 | -2.31 | Upgrade
|
| Change in Accounts Payable | -3.27 | -3.27 | -15.12 | 77.63 | 36.86 | 11.62 | Upgrade
|
| Change in Other Net Operating Assets | 0.07 | 0.07 | 0.26 | 0.9 | 3.84 | 0.43 | Upgrade
|
| Operating Cash Flow | 122.15 | 118.33 | 132.3 | 132.82 | 103.82 | 85.55 | Upgrade
|
| Operating Cash Flow Growth | -0.95% | -10.56% | -0.39% | 27.93% | 21.36% | 7.65% | Upgrade
|
| Capital Expenditures | -31.94 | -27.94 | -54.92 | -67.31 | -31.47 | -21.36 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.86 | 0.55 | 0.1 | 0.69 | 0.55 | - | Upgrade
|
| Investment in Securities | 32 | -7 | -288.69 | -29.31 | 5 | -69 | Upgrade
|
| Other Investing Activities | 18.23 | 19.38 | 10.54 | 7.73 | 6.08 | 3.47 | Upgrade
|
| Investing Cash Flow | 19.15 | -15.01 | -332.98 | -88.21 | -19.84 | -86.89 | Upgrade
|
| Short-Term Debt Issued | - | - | 338.88 | 49.8 | 31.15 | 49.09 | Upgrade
|
| Long-Term Debt Issued | - | 32.22 | - | - | - | - | Upgrade
|
| Total Debt Issued | 37.01 | 32.22 | 338.88 | 49.8 | 31.15 | 49.09 | Upgrade
|
| Short-Term Debt Repaid | - | - | -49.57 | -41 | -40.1 | -20.22 | Upgrade
|
| Long-Term Debt Repaid | - | -50.51 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -50.74 | -50.51 | -49.57 | -41 | -40.1 | -20.22 | Upgrade
|
| Net Debt Issued (Repaid) | -13.73 | -18.28 | 289.31 | 8.8 | -8.95 | 28.87 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 20.08 | Upgrade
|
| Common Dividends Paid | -58.94 | -59.01 | -59.78 | -55.33 | -46.32 | -35.07 | Upgrade
|
| Other Financing Activities | 14.58 | -7.92 | -1.36 | -1.99 | - | -5.12 | Upgrade
|
| Financing Cash Flow | -58.08 | -85.21 | 228.17 | -48.52 | -55.27 | 8.76 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.97 | 1.22 | -0.01 | 2.56 | -0.28 | -1 | Upgrade
|
| Net Cash Flow | 84.19 | 19.33 | 27.47 | -1.35 | 28.43 | 6.42 | Upgrade
|
| Free Cash Flow | 90.21 | 90.39 | 77.38 | 65.5 | 72.35 | 64.19 | Upgrade
|
| Free Cash Flow Growth | 12.90% | 16.82% | 18.13% | -9.46% | 12.71% | 226.94% | Upgrade
|
| Free Cash Flow Margin | 10.11% | 10.24% | 9.22% | 9.30% | 11.73% | 12.08% | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.39 | 0.32 | 0.28 | 0.31 | 0.28 | Upgrade
|
| Cash Income Tax Paid | 59.21 | 58.72 | 15.47 | 40.46 | 40.42 | 38.13 | Upgrade
|
| Levered Free Cash Flow | 32.58 | 37.65 | 55.32 | 114.88 | 45.79 | 41.73 | Upgrade
|
| Unlevered Free Cash Flow | 32.58 | 37.65 | 58 | 115.64 | 46.54 | 42.19 | Upgrade
|
| Change in Net Working Capital | 97.22 | 95.9 | 29.06 | -70.23 | 18.68 | 29.58 | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.